Rimegepant to prevent migraine attacks in children
Treatments studied
Part of Brain & nervous system, Ear, nose & throat, Eyes & vision clinical trials.
This trial studies whether rimegepant can reduce how often migraine attacks happen in children and teens. It also looks at safety and how well the treatment fits day-to-day life and school activities.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Ages 6 to under 18, and able to take part with consent/assent
- Migraine history for at least 6 months
- Not too few and not too many headache days each month (limits must be met before and during the study)
- Migraine disability score from 11 to 50 (mild to moderate impact on daily life)
- You must be able to tell migraine attacks apart from other headache types
- Weigh at least 40 kg at screening (or at least 15 kg if in the child cohort)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if the drug rimegepant can help prevent migraine attacks in women. It aims to see how well it works in real life in China.
This trial tests whether a medication called rimegepant can prevent migraines when you take it before a known trigger (like exercise or stress). It is for people who get migraines often and can predict when one might happen.
This study tests a medicine called rimegepant to see if it helps prevent migraines. If you have migraine at least 4 days per month, this might be for you.
This trial studies how well a “gepant” medicine works for different types of migraine and how tolerable it is. It may help if you have frequent migraines and you can keep a headache diary as the study asks.
This study tests how safe ubrogepant is and whether it helps treat an individual migraine attack in children and teens. It focuses on measuring side effects and whether headaches improve 2 hours after taking the study medicine.
This observational study looks at health outcomes for moms, babies, and infants after rimegepant is used during pregnancy for migraine. It may help doctors understand potential risks or reassuring safety information for future pregnancies.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.